Health Check: ‘We’ve only just started’, Mesoblast tells investors at inaugural show-and-tell

Mesoblast has outlined plans to double initial revenues and develop stem cell drugs for lower back pain, heart failure and ... Read More The post Health Check: ‘We’ve only just started’, Mesoblast tells investors at inaugural show-and-tell appeared first on Stockhead .

Go to News Site